PRECISION OPTICS CORPORATION, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PRECISION OPTICS CORPORATION, INC. (POCI) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$32.05 thousand for the 9-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-15
- PRECISION OPTICS CORPORATION, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$1.88K, a 127.04% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$26.65K, a 272.23% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$3.52K.
- PRECISION OPTICS CORPORATION, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $5.94K, a 11.71% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $24.11K.
- PRECISION OPTICS CORPORATION, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$46.31K, a 1311.17% decline from fiscal 2014.
- PRECISION OPTICS CORPORATION, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $3.82K.
- PRECISION OPTICS CORPORATION, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$6.56K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$1.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$28.53K derived: sum of 2 quarters · filed 2017-05-15 | -$32.05K 10-Q · filed 2017-05-15 | -$26.11K derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-12-31 | -$26.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | -$30.18K 10-Q · filed 2017-02-14 | -$24.23K derived: sum of 3 quarters · filed 2017-02-14 | -$17.30K derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-09-30 | -$3.52K 10-Q · filed 2016-11-14 | $2.42K derived: sum of 2 quarters · filed 2016-11-14 | $9.36K derived: sum of 3 quarters · filed 2017-05-15 | $24.83K derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-06-30 | $5.94K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $12.88K derived: sum of 2 quarters · filed 2017-05-15 | $28.35K derived: sum of 3 quarters · filed 2017-05-15 | $24.11K 10-K · filed 2016-09-28 |
| 2016-03-31 | $6.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $22.41K derived: sum of 2 quarters · filed 2017-05-15 | $18.16K 10-Q · filed 2017-05-15 | $24.89K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $15.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | $11.22K 10-Q · filed 2017-02-14 | $17.95K derived: sum of 3 quarters · filed 2017-02-14 | $14.64K derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-09-30 | -$4.25K 10-Q · filed 2016-11-14 | $2.48K derived: sum of 2 quarters · filed 2016-11-14 | -$833.00 derived: sum of 3 quarters · filed 2016-11-14 | -$33.26K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $6.73K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $3.42K derived: sum of 2 quarters · filed 2016-09-28 | -$29.01K derived: sum of 3 quarters · filed 2016-09-28 | -$46.31K 10-K · filed 2016-09-28 |
| 2015-03-31 | -$3.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-16 | -$35.74K derived: sum of 2 quarters · filed 2016-05-16 | -$53.04K 10-Q · filed 2016-05-16 | -$48.35K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | -$32.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | -$49.73K 10-Q · filed 2016-02-16 | -$45.04K derived: sum of 3 quarters · filed 2016-02-16 | -$38.53K derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-09-30 | -$17.30K 10-Q · filed 2015-11-12 | -$12.62K derived: sum of 2 quarters · filed 2015-11-12 | -$6.10K derived: sum of 3 quarters · filed 2015-11-12 | -$4.96K derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $4.69K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13 | $11.20K derived: sum of 2 quarters · filed 2015-10-13 | $12.35K derived: sum of 3 quarters · filed 2015-10-13 | $3.82K 10-K · filed 2015-10-13 |
| 2014-03-31 | $6.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | $7.66K derived: sum of 2 quarters · filed 2015-05-14 | -$866.00 10-Q · filed 2015-05-14 | -$8.48K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $1.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | -$7.38K 10-Q · filed 2015-02-17 | -$14.99K derived: sum of 3 quarters · filed 2015-02-17 | |
| 2013-09-30 | -$8.52K 10-Q · filed 2014-11-13 | -$16.14K derived: sum of 2 quarters · filed 2014-11-13 | ||
| 2013-06-30 | -$7.61K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -$6.56K 10-K · filed 2014-09-29 | ||
| 2013-03-31 | $1.05K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |